Researchers led by Nobel laureate David Baker have harnessed deep learning methods to design peptides capable of binding intrinsically disordered proteins (IDPs), which traditionally have been challenging targets due to their flexible structures. These AI-powered tools, including RFdiffusion, enable generation of binders from extensive protein databases, marking a significant technological leap in addressing IDPs' biological roles and therapeutic potential.